# Evaluation of the Atlas Genetics io® CTNG System

> **NCT03071510** · — · COMPLETED · sponsor: **Binx Health Limited** · enrollment: 7128 (actual)

## Conditions studied

- Chlamydia Trachomatis
- Gonorrhea

## Interventions

- **DEVICE:** Atlas Genetics io® system

## Key facts

- **NCT ID:** NCT03071510
- **Lead sponsor:** Binx Health Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-18
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-08-30
- **Target enrollment:** 7128 (ACTUAL)
- **Last updated:** 2020-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03071510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03071510, "Evaluation of the Atlas Genetics io® CTNG System". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03071510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
